{"version":"1.0","type":"rich","provider_name":"Tech & Business","provider_url":"https://techandbusiness.org","title":"Turning GWAS signals into drug targets with scalable CRISPR","author_name":"T&B Newswire · Tech & Business","thumbnail_url":"https://www.nygenome.org/wp-content/uploads/21026_shutterstock_2533861023_605738.jpg","width":600,"height":400,"html":"<blockquote class=\"tb-newswire-embed\" style=\"max-width:600px;border-left:3px solid #22d3ee;padding:12px 16px;margin:0;font-family:-apple-system,system-ui,sans-serif;background:#09090b;border-radius:0 8px 8px 0;\">\n      <p style=\"margin:0 0 8px;font-size:10px;font-weight:600;letter-spacing:0.1em;color:#71717a;text-transform:uppercase;\">T&B NEWSWIRE · Tech & Business</p>\n      <p style=\"margin:0 0 8px;font-size:18px;font-weight:700;line-height:1.3;color:#fff;\"><a href=\"https://techandbusiness.org/newswire/xa2LJ5eTlv3o3Jn7j0JWe2\" style=\"color:#fff;text-decoration:none;\">Turning GWAS signals into drug targets with scalable CRISPR</a></p>\n      <p style=\"margin:0;font-size:14px;color:#a1a1aa;line-height:1.5;\">Dr. Neville Sanjana, Core Faculty Member at the New York Genome Center and Professor of Biology and Neuroscience at New York University, contributed to Drug Target Review on scalable CRISPR screening ...</p>\n    </blockquote>"}